Complete Story
HB 341 passes Ohio House of Representatives unanimously!
In February, HB 341 officially passed the Ohio House of Representatives unanimously, after months of vetting in the House Health Committee. HB 341, sponsored by Representative Tim Ginter (R-Salem), seeks to expand the portfolio of medications that pharmacists can administer to patients.
In the 131st General Assembly, OPA was successful in pushing to enact legislation that allowed pharmacists to administer certain types of long-acting injectable medications, which include opioid antagonists for drug addiction or alcohol dependence; antipsychotic drugs; hydroxyprogesterone for pregnant women; medroxyprogesterone for non-pregnant women; and cobalamin (including cyanocobalamin or hydroxycobalamin).
HB 341 would expand the law beyond opioid antagonists, and allow pharmacists to administer any drug used for drug addiction or alcohol dependence.
OPA Independent SIG Chair Mimi Hart and OPA government affairs director Antonio Ciaccia both provided testimony in support of the bill in Health Committee.
OPA thanks Representative Ginter for his tireless advocacy on the bill. We also thank Health Committee Chairman Scott Lipps and the Ranking Minority Member Thomas West for working to advance the bill through committee. Lastly, big thanks to Ohio Speaker of the House Larry Householder for bringing the bill to the floor. We now will work to advance the bill through the Senate.
